Smith & Nephew Plc (LSE: SN)
Smith & Nephew Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Smith & Nephew Plc Company Info
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
News & Analysis
FTSE Shares That Soared and Plunged This Week
A look back at the week in London.
Should I Invest in Smith & Nephew?
Can Smith & Nephew's total return beat the wider market?
3 Neil Woodford Fast Dividend Growers
Smith & Nephew, Wm. Morrison Supermarkets, and Serco Group are three of the master investor's fastest dividend growers.
Profits Drop 4% at Smith & Nephew
Medical device company Smith & Nephew announces $300 million share buyback despite profit decline.
Should You Buy Smith & Nephew Today?
How attractive are the shares of Smith & Nephew (LON: SN)?
3 More FTSE 100 Shares Going Ex-Dividend Next Week
It's ex-dividend time for Tullow Oil, Smith & Nephew, and Resolution.
Neil Woodford's Latest Buys and Sells
G4S, Smith & Nephew, Vodafone Group, BG Group, and Tate & Lyle are among the City superinvestor's biggest buys and sells.
The Men and Women Who Run Smith and Nephew
What you need to know about the top executives of medical equipment group Smith and Nephew plc.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.